Vivatmo pro for professionals
Professional FeNO monitoring for medical practices and clinical settings
Vivatmo pro was specially developed for professional use in doctors’ practices and clinics. Thanks to its simple measuring procedure1 and intuitive use2, it can be smoothly integrated into the workflow of professional practices. Both physicians and patients benefit from the more efficient patient care.
These features make Vivatmo pro a unique solution:
Easy measurement thanks to intuitive user guidance
Results are available immediately following the measurement
Flexibility of use thanks to cordless and mobile handheld
Optimum and direct integration into practice workflows
Vivatmo pro: Explore the latest Generation 2.0
Bosch Healthcare Solutions GmbH launched Vivatmo pro in 2017. Since then, our engineers, UX designers and many others have continuously improved it. Always with the goal in mind to understand and satisfy users' needs even better. Learn more about the latest product features in Generation 2.0.
Vivatmo in the doctor’s practice
What does Vivatmo pro detect?
You can use Vivatmo to determine the level of the established biomarker nitric oxide (NO) in exhaled air and thus monitor allergic airway inflammation in your patients.
How does Vivatmo measure FeNO?
Your patient breathes calmly into the handheld through the disposable mouthpiece. After successful measurement, the result is available within a few seconds. FeNO measurement is quick, easy, repeatable and non-invasive for your patients.
An initial scientific study investigating the Vivatmo pro, NIOX VERO (Circassia) and CLD 88 sp (Ecomedics) breath analysers showed that absolute measurements of exhaled NO in patients with FeNO values in the 0-70 ppb range produced comparable readings. However, the highest success rate for obtaining two valid FeNO readings without failed attempts was achieved with the Vivatmo pro.3
What does the FeNO value tell you?
FeNO is formed in the respiratory tract by inflammatory cells. The NO concentration in the exhaled air therefore reflects the degree of inflammation in the respiratory tract – the more inflammatory cells there are, the more NO is produced. The NO concentration in exhaled air is measured in parts per billion (ppb). According to the asthma guidelines, increased FeNO values indicate allergic inflammation and thus support the diagnosis of allergic asthma.4
What are the advantages of FeNO measurement for you and your patients?
Using the FeNO value, you can detect allergic inflammation of the respiratory tract in your patients and closely monitor the progression of the inflammation, also during therapy. National and international guidelines recommend FeNO measurements for diagnosis, therapy management and monitoring of asthma patients.4-6 Increased FeNO values indicate a worsening of the course of the disease even before a conspicuous pulmonary function test result and therefore allow early therapeutic countermeasures to be taken.7
Our products are CO2 neutral
Responsibility means taking climate action.
By making our products CO2 neutral, from the Vivatmo oxycap consumer product to the Vivatmo pro and Vivatmo me breath analysers, we aim to make a further contribution to climate action.
Do you have any questions or are you interested in Vivatmo pro?
*Not all products are available in all regions. Check with your local representative for availability in specific markets.
1 Vivatmo me-Produkttest C: 28 Teilnehmer (Asthmatiker aus Deutschland);
2 Gebrauchsanweisung und Technisches Datenblatt Vivatmo pro;
3 Korn S, et al. Respiration. 2020; 99(1): 1-8;
4 Buhl et al. Pneumologie 2017; 71: 849–919;
5 Dweik et al. Am J Respir Crit Care Med 2011;184: 602–15;
6 NICE Guideline Asthma - diagnosis and monitoring (November 2017, https://www.nice.org.uk/guidance/ng80/evidence/full-guideline-asthma-diagnosis-and-monitoring-pdf-4656178047)
7 Bodini et al. J Breath Res. 2017; 27;11(4);
8 Prof. Dr. med. Felix Herth, Medizinischer Direktor der Thoraxklinik Heidelberg, Universitätsklinikum Heidelberg, 2016.